• Published in Events

Scholars International Conference on STD, HIV and AIDS - November 18-19, 2019 at Tokyo, Japan

Scholars International Conference on STD, HIV and AIDS Research Short Name: STD Research 2019
November 18-19, 2019 at Tokyo, Japan.

Theme: Transcending Barriers, Creating Opportunities

July, 2018:  Scholars Conferences, host of Scholars International Conference on STD, HIV and AIDS Research, will focus on the Recent Progress and Future Outlook at STD, AIDS and HIV and Infectious diseases. STD Research-2019 summons participants from paramount universities, research institutions and diagnostic companies to exhibit their research expertise on all aspects of this rapidly expanding field. The event is going to held at Tokyo, Japan, from 18-19 November 2019.

The conference will feature presentations by top Doctors, medical industries, professionals as well as renowned experts in regulatory field from all around the globe. Dr.Ramneek Ahluwalia - CEO, HEAIDS; Hiroshi Ohrui, Yokohama University of Pharmacy, Japan; Mustafa Younis, Jackson State University, USA and more will present their lectures during the conference. These are all among other exciting and high profile individuals who have shared knowledge of their experience and the role of STD Research 2019 Conference.

Scholars Conferences is a proud to present the highly anticipated “Scholars International Conference on STD, HIV and AIDS Research" (STD Research 2019) during November 18-19, 2019 at Tokyo, Japan.

In addition, attendees will enjoy special events and lecturers featuring specialists and top scholars. It is a perfect platform for educators, practitioners and researchers to exchange & share their experiences, research findings about all aspects of Control and Prevention of STD-AIDS.

STD Research 2019 will lay a platform for scientists, researchers, professors and doctors to discuss about recent research on control and prevention STD/AIDS and their treatment. STD Research 2019 is designed to provide current education that to discuss the issues affecting the diagnosis, treatment of STD AIDS their control and prevention. Scholars International Conference on STD, HIV and AIDS Research foster the progress in the field and share with your expertise to what promises to be a very comprehensive and exciting meeting.

If you would like to know more information about this conference, Contact:  Bindu

Tel.: 44 2035140512

Email:  This email address is being protected from spambots. You need JavaScript enabled to view it.  

Website: https://scholarsconferences.com/std-hiv-aids-research/


Smoking and HIV

Recent Studies on smoking in people with HIV, published NAM Factsheet, fount that found that people living with HIV appear to metabolise nicotine at a faster rate than HIV-negative people.

This could explain why people with HIV are more likely to become smokers and find it harder to quit. People who metabolise nicotine at a slower rate smoke fewer cigarettes, are less dependent on nicotine and are more likely to succeed in quitting smoking. This was an innovative study – other researchers should try to do the same experiment and see if they get the same results.

The other study found that frequent cannabis smoking is a risk factor for lung disease in men with HIV, in addition to cigarette smoking as a risk factor. It is well known that people with HIV have an increased risk of lung disease. This is partly because of the high rates of smoking among HIV-positive individuals, as well as damage caused by HIV and immune suppression.

The research involved both HIV-positive and HIV-negative men. During ten years of follow-up, men living with HIV who had smoked cannabis every week for at least a year were more likely to have lung disease due to an infection (33%) than men living with HIV who did not use cannabis (22%). Similarly, cannabis smokers were more likely to have bronchitis (21%) than men who did not smoke cannabis (17%).

In contrast, in the men who did not have HIV, cannabis was not linked to either form of lung disease. This suggests that people with HIV are especially vulnerable to lung disease caused by cannabis smoking.